Improved short-term spatial memory but impaired reversal learning following the dopamine D2 agonist bromocriptine in human volunteers
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Rationale Studies in humans of cognitive effects of dopaminergic drugs have largely focused on tasks of working memory, with a few studies also examining executive function.Objectives This study was designed to investigate the effects of 1.25 mg of the dopamine D(2) agonist bromocriptine on spatial working memory, planning and discrimination reversal learning in young healthy volunteers.Methods Twenty volunteers were tested in a double-blind, placebo-controlled, cross-over design. The cognitive assessment included tests taken from the Cambridge Neuropsychological Test Automated Battery (CANTAB) designed to test visuo-spatial recognition memory and spatial working memory. In addition, tests of spatial planning and discrimination reversal learning were used to assess the more general effects of bromocriptine. Tests of subjective feelings and motivation were also incorporated into the battery.Results Bromocriptine enhanced the spatial memory span of subjects, whilst impairing their ability to reverse a learned probabilistic discrimination. Tests of recognition memory and planning were unaffected by the drug. The findings were not explained by changes in subjective mood or motivational measures.Conclusions The pattern of findings observed here mirror medication-dependent observations seen in Parkinson's disease. The results are discussed with reference to the different anatomical networks known to subserve performance of the differentially affected tasks.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In healthy humans, the D2 receptor antagonist sulpiride enhances reward-based reversal learning (van der Schaaf et al 2014), whereas a D2 receptor agonist bromocriptine impairs probabilistic reversal learning (Mehta et al 2001).”
From Prefrontal cortex executive processes affected by stress in health and disease (2018) · cites this paper as Mehta et al 2001
Citations
Cites
Statistical principles in experimental design.
Winer, B. J. (1962) · McGraw-Hill Book Company · doi:10.1037/11774-000 · Cited by 26,755
A neural substrate of prediction and reward
Schultz, W., Dayan, P., & Montague, P. R. (1997) · Science · doi:10.1126/science.275.5306.1593 · Cited by 9,388 · cited 1×
“Therefore, Swainson et al. (2000) hypothesised that the impaired reversal learning performance of medicated PD patients resulted from a disrupting “overdosing” of the dopamine innervation to the ventro-medial head of the caudate, which has anatomical connections to the lateral orbito-frontal cortex ( Alexander et al.…”
BackgroundINTERHEMISPHERIC DIFFERENCES IN THE LOCALIZATION OF PSYCHOLOGICAL PROCESSES IN MAN
MILNER, B. (1971) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a070866 · Cited by 2,329 · cited 1×
“This test of short-term spatial memory capacity is based on the Corsi Block Tapping Task ( Milner 1971 ).”
MethodThe use of analogue scales in rating subjective feelings
BOND, A., & LADER, M. (1974) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1974.tb02285.x · Cited by 1,972
Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's Disease
Kish, S. J., Shannak, K., & Hornykiewicz, O. (1988) · New England Journal of Medicine · doi:10.1056/nejm198804073181402 · Cited by 1,953
Dissociation in prefrontal cortex of affective and attentional shifts
Dias, R., Robbins, T. W., & Roberts, A. C. (1996) · Nature · doi:10.1038/380069a0 · Cited by 1,527 · cited 2×
“Regions of the lateral prefrontal cortex are known to contribute to visuo-spatial memory performance (Jonides et al. 1993; Baker et al. 1996) and the orbito-frontal cortex is implicated in reversal learning ( Dias et al. 1996 ).”
BackgroundSelf-citationThe two‐period cross‐over clinical trial.
Hills, M., & Armitage, P. (1979) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1979.tb05903.x · Cited by 1,395 · cited 1×
“This precautionary analysis is advocated by Hills and Armitage (1979) .”
BackgroundD1 Dopamine Receptors in Prefrontal Cortex: Involvement in Working Memory
Sawaguchi, T., & Goldman-Rakic, P. S. (1991) · Science · doi:10.1126/science.1825731 · Cited by 1,364 · cited 1×
“Since direct application of D2 agents into the prefrontal cortex of non-human primates has no effect on delayed-memory performance ( Sawaguchi and Goldman-Rakic 1991, 1994 ), it has been hypothesised that the action of quinpirole at other dopamine receptors (D 3 /D 4 ) or within the striatum may be responsible for its…”
BackgroundPlanning and spatial working memory following frontal lobe lesions in man
Owen, A. M., Downes, J. J., Sahakian, B. J., Polkey, C. E., & Robbins, T. W. (1990) · Neuropsychologia · doi:10.1016/0028-3932(90)90137-d · Cited by 1,245 · cited 8×
“One strategy that is known to be effective ( Owen et al. 1990 ) is to begin each search sequence with a particular box and then, once a token is found, to return to the same starting point and following the same search sequence (removing locations from the sequence when tokens are found).”
BackgroundMethodResultSelf-citationSpatial working memory in humans as revealed by PET
Jonides, J., Smith, E. E., Koeppe, R. A., Awh, E., Minoshima, S., & Mintun, M. A. (1993) · Nature · doi:10.1038/363623a0 · Cited by 1,194 · cited 1×
“Regions of the lateral prefrontal cortex are known to contribute to visuo-spatial memory performance ( Jonides et al. 1993; Baker et al. 1996) and the orbito-frontal cortex is implicated in reversal learning (Dias et al. 1996).”
Background
Cited by
Items 101–200 of 238
Gibbs, S. E. B., & D’Esposito, M. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.11.055 · Cited by 49
Deiana, S., Watanabe, A., Yamasaki, Y., Amada, N., Kikuchi, T., Stott, C. G., & Riedel, G. (2015) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000178 · Cited by 54
“D2 receptors are involved in working memory (Kimberg et al., 2001; Mehta et al., 2001, 2004), and it has been suggested that their role is more relevant to executive function than to the maintenance of working memory (Roesch-Ely et al., 2005).”
BackgroundBromocriptine therapy: Review of mechanism of action, safety and tolerability
Naz, F., Malik, A. R., Riaz, M., Mahmood, Q., Mehmood, M. H., Rasool, G., Mahmood, Z., & Abbas, M. (2022) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13678 · Cited by 54
“Similarly, bromocriptine has been seen to improve the cognitive control and spatial working memory span in animal models(221) and in healthy human subjects.(222,223) Bromocriptine, whenever”
BackgroundDopamine Modulation of the Prefrontal Cortex and Cognitive Function
Seamans, J. K., & Robbins, T. W. (2010) · The Dopamine Receptors · doi:10.1007/978-1-60327-333-6_14 · Cited by 39
Self-citationOpgen‐Rhein, C., Neuhaus, A. H., Urbanek, C., Hahn, E. W., Sander, T., & Dettling, M. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm155 · Cited by 50
Dopamine D2 Receptors Enhance Population Dynamics in Primate Prefrontal Working Memory Circuits
Ott, T., & Nieder, A. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw244 · Cited by 52
NMDA receptor–related mechanisms of dopaminergic modulation of tDCS-induced neuroplasticity
Ghanavati, E., Salehinejad, M. A., Melo, L., Nitsche, M. A., & Kuo, M. (2022) · Cerebral Cortex · doi:10.1093/cercor/bhac028 · Cited by 50
“A comparable effect was also described at the behavioral level, where L-Dopa or D2 activation alone impaired associative learning in primates and humans (Mehta et al. 2001; Gallant et al. 2016; Vo et al. 2017; Marino and Levy 2019).”
5.4 Dopaminergic Modulation of Flexible Cognitive Control in Humans
Cools, R., & D’Esposito, M. (2009) · Dopamine Handbook · doi:10.1093/acprof:oso/9780195373035.003.0017 · Cited by 46
MacDonald, A. A., Seergobin, K. N., Owen, A. M., Tamjeedi, R., Monchi, O., Ganjavi, H., & MacDonald, P. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074044 · Cited by 46
“Attempting to isolate encoding from other influences on memory is particularly important given that immediate or working memory processes have been shown to improve with dopaminergic medication in PD [52–60] and in healthy young adults [61–66].”
BackgroundSchlösser, R. G. M., Nenadic, I., Wagner, G., Zysset, S., Koch, K., & Sauer, H. (2009) · Synapse · doi:10.1002/syn.20621 · Cited by 44
Consideration of species differences in developing novel molecules as cognition enhancers
Young, J. W., Jentsch, J. D., Bussey, T. J., Wallace, T. L., & Hutcheson, D. M. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.10.002 · Cited by 42
Drugs and Human Memory (Part 2): Clinical, Theoretical, and Methodologic Issues
Ghoneim, M. M., & Warner, D. O. (2004) · Anesthesiology · doi:10.1097/00000542-200405000-00033 · Cited by 55
da Costa, A. L. C., Peppe, A., Mazzù, I. D., Longarzo, M., Caltagirone, C., & Carlesimo, G. A. (2014) · Behavioural Neurology · doi:10.1155/2014/260896 · Cited by 47
Impulsivity, Stimulant Abuse, and Dopamine Receptor Signaling
London, E. D. (2016) · Advances in pharmacology · doi:10.1016/bs.apha.2016.01.002 · Cited by 43
Linden, J., James, A. S., McDaniel, C., & Jentsch, J. D. (2018) · eNeuro · doi:10.1523/eneuro.0229-17.2018 · Cited by 45
“Human subjects who received bromocriptine, a D2 agonist, also showed decreased performance in a probabilistic reversal learning task (Mehta et al., 2001), though the D3-preferring agonist, pramiprexole, did not alter perseverative responses in healthy volunteers in a similar test (Ersche et al.,…”
BackgroundPharmacological Strategies for Enhancing Cognition in Schizophrenia
Barch, D. M. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_39 · Cited by 42
Metha, J. A., Brian, M. L., Oberrauch, S., Barnes, S. A., Featherby, T. J., Bossaerts, P. L., Murawski, C., Hoyer, D., & Jacobson, L. H. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2019.00270 · Cited by 41
“A PRL task involves subjects making a series of choices between binary options, one with high and low probabilities, respectively (e.g., in both rodent and human PRL task, 80% and 20% reward contingencies are commonly used (Mehta et al., 2001; Bari et al., 2010; Dalton et al., 2014)).”
BackgroundMatrenza, C., Hughes, J.-M., Kemp, A. H., Wesnes, K. A., Harrison, B. J., & Nathan, P. J. (2004) · Journal of Psychopharmacology · doi:10.1177/0269881104040215 · Cited by 39
Translational Assessments of Reward and Anhedonia: A Tribute to Athina Markou
Der-Avakian, A., & Pizzagalli, D. A. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.02.008 · Cited by 36
“Regarding dopamine, administration of a dopamine D2 agonist impaired reversal learning in humans (34), while administration of a dopamine D3 agonist impaired reversal learning in rats (35).”
Horst, N. K., Jupp, B., Roberts, A. C., & Robbins, T. W. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-018-0272-9 · Cited by 38
“Mehta et al (2001) found that the D2-type agonist bromocriptine impaired reversal learning in healthy volunteers at doses improving spatial working memory, suggesting different neural substrates for the optimal performance of these two tasks.”
Self-citationLevodopa impairs probabilistic reversal learning in healthy young adults
Vo, A., Seergobin, K. N., Morrow, S. A., & MacDonald, P. A. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4322-x · Cited by 41
Kourosh‐Arami, M., Komaki, A., & Zarrindast, M. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220418115503 · Cited by 40
Housden, C. R., Morein‐Zamir, S., & Sahakian, B. J. (2011) · Wiley eBooks · doi:10.1002/9781444393552.ch7 · Cited by 38
Self-citationHyperprolactinemia impairs object recognition without altering spatial learning in male rats
Torner, L., Tinajero, E., Lajud, N., Quintanar‐Stephano, A., & Olvera‐Cortés, M. E. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.05.031 · Cited by 33
Alsiö, J., Phillips, B. U., Sala‐Bayo, J., Nilsson, S. R. O., Calafat, T., Rizwand, A., Plumbridge, J. M., López‐Cruz, L., Dalley, J. W., Cardinal, R. N., et al. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05296-y · Cited by 35
“1999) and healthy volunteers (Mehta et al. 2001), as well as by experiments linking variation in the DRD2 gene to reversal learning (Smith et al.”
BackgroundSelf-citationWorking memory span capacity improved by a D2 but not D1 receptor family agonist
Tarantino, I. S., Sharp, R. F., Geyer, M. A., Meves, J. M., & Young, J. W. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.12.037 · Cited by 36
The modulatory effects of dopamine D1 and D2 receptor function on object working memory in humans
Bartholomeusz, C. F., Box, G., Van Rooy, C., & Nathan, P. J. (2003) · Journal of Psychopharmacology · doi:10.1177/0269881103017001688 · Cited by 30
Parr, A. C., Sydnor, V. J., Calabro, F. J., & Luna, B. (2024) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2024.101399 · Cited by 33
Apomorphine effects on episodic memory in young healthy volunteers
Montoya, A., Lal, S., Menear, M., Duplessis, E., Thavundayil, J. X., Schmitz, N., & Lepage, M. (2007) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2007.07.012 · Cited by 31
Tyson, P. J., Laws, K. R., Flowers, K. A., TYSON, A., & Mortimer, A. M. (2006) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2006.01534.x · Cited by 31
Shang, C., & Gau, S. S. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000783 · Cited by 28
“, 2008) and humans (Mehta et al., 2001) highlights an important role of dopamine in modulating SWM, there are few data concerning the associations of DAT1 with SWM, and these have only been shown in animal models (Li et al.”
BackgroundCNTRICS Imaging Biomarkers Final Task Selection: Long-Term Memory and Reinforcement Learning
Ragland, J. D., Cohen, N. J., Cools, R., Frank, M., Hannula, D. E., & Ranganath, C. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr168 · Cited by 29
The Schizophrenia Spectrum Personality Disorders
Chemerinski, E., & Siever, L. J. (2010) · Wiley eBooks · doi:10.1002/9781444327298.ch5 · Cited by 27
Xu, H., Yang, H.-J., & Rose, G. M. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.07.025 · Cited by 29
Behavioral Animal Models to Assess Pro-cognitive Treatments for Schizophrenia
Young, J. W., Amitai, N., & Geyer, M. A. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25758-2_3 · Cited by 29
Calaminus, C., & Hauber, W. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.04.046 · Cited by 34
Drug Predictive Cues Activate Aversion-Sensitive Striatal Neurons That Encode Drug Seeking
Wheeler, D. S., Robble, M. A., Hebron, E. M., Dupont, M. J., Ebben, A. L., & Wheeler, R. A. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4823-14.2015 · Cited by 27
Selvaggi, P., Pergola, G., Gelao, B., Carlo, P. D., Nettis, M. A., Amico, G., Fazio, L., Rampino, A., Sambataro, F., Blasi, G., et al. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy022 · Cited by 27
“25mg was chosen as previous studies consistently reported that it was able to modulate behavior and BOLD signal during WM and was not associated with significant adverse events (Luciana et al. 1992; Mehta et al. 2001).”
MethodAmphetamine effects on MATRICS Consensus Cognitive Battery performance in healthy adults
Chou, H., Talledo, J., Lamb, S. N., Thompson, W. K., & Swerdlow, N. R. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2948-x · Cited by 26
“2010a, b), and AMPH and other dopamine agonists may be particularly effective in enhancing neurocognition in healthy subjects with low basal performance levels (Kimberg et al. 1997; Kimberg and D’Esposito 2003; Mattay et al. 2000, 2003; Mehta et al. 2001; Swerdlow 2011), and in individuals carrying certain genetic bio…”
BackgroundVo, A., Hiebert, N. M., Seergobin, K. N., Solcz, S., Partridge, A., & MacDonald, P. A. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00784 · Cited by 25
“Finally, and further supporting our interpretation of our findings, even in healthy volunteers, administration of dopaminergic therapy has been shown to worsen learning (Mehta et al., 2001; Breitenstein et al., 2006).”
ResultTowards Medication-Enhancement of Cognitive Interventions in Schizophrenia
Chou, H., Twamley, E. W., & Swerdlow, N. R. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25758-2_4 · Cited by 24
“…performance in individuals with low basal performance levels (Kimberg et al. 1997; Kimberg and D’Esposito 2003; Mattay et al. 2000, 2003; Mehta et al. 2001; Swerdlow et al. 2011) and in individuals carrying certain genetic biomarkers or related phenotypes (Ersche et al. 2011; Fleming…”
BackgroundVollenweider, F. X., Liechti, M. E., & Paulus, M. P. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105053287 · Cited by 25
Pramipexole Impairs Stimulus-Response Learning in Healthy Young Adults
Gallant, H., Vo, A., Seergobin, K. N., & MacDonald, P. A. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00374 · Cited by 26
“These investigations have revealed medication-related impairment in associative (Breitenstein et al., 2006), probabilistic reversal (Mehta et al., 2001), and reinforcement learning (Pizzagalli et al., 2008; Santesso et al., 2009) in healthy adults.”
BackgroundInfluentialMaladaptive striatal plasticity and abnormal reward‐learning in cervical dystonia
Gilbertson, T., Humphries, M. D., & Steele, J. D. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14414 · Cited by 22
“Selective blockade of D2 receptors in humans, or destruction of D2 expressing MSN’s in animals, leads to impairments in the reversal learning phase of reward learning tasks (Mehta et al., 2001; Nakanishi et al., 2014).”
BackgroundEffect of apomorphine on cognitive performance and sensorimotor gating in humans
Schellekens, A., Grootens, K. P., Neef, C., Movig, K. L. L., Buitelaar, J. K., Ellenbroek, B. A., & Verkes, R. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1686-1 · Cited by 26
Goetghebeur, P., & Swartz, J. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116645269 · Cited by 26
Affective Bias and Response Modulation Following Tyrosine Depletion in Healthy Adults
Vrshek‐Schallhorn, S., Wahlstrom, D., Benolkin, K., White, T. J. H., & Luciana, M. M. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301172 · Cited by 24
Novelty processing and memory formation in Parkinson׳s disease
Schomaker, J., Berendse, H. W., Foncke, E. M. J., van der Werf, Y. D., van den Heuvel, O. A., Theeuwes, J., & Meeter, M. (2014) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2014.07.016 · Cited by 23
Cognitive Control and Schizophrenia: Psychological and Neural Mechanisms
Barch, D. M., & Braver, T. S. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511720413.007 · Cited by 25
D’Esposito, M. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)88011-0 · Cited by 28
The acute effect of Hypericum perforatum on short-term memory in healthy adults
Yechiam, E., Ben-Eliezer, D., Ashby, N. J. S., & Bar-Shaked, M. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5088-0 · Cited by 23
Effects of COMT Genotypes on Working Memory Performance in Fibromyalgia Patients
Ferrera, D., Gómez‐Esquer, F., Peláez, I., Barjola, P., Fernandes-Magalhaes, R., Carpio, A., Lahoz, M. E. D., Díaz‐Gil, G., & Mercado, F. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082479 · Cited by 21
Manza, P., Kojori, E. S., Demiral, Ş. B., Wiers, C. E., Zhang, R., Giddens, N. T., McPherson, K. L., Biesecker, E., Dennis, E., Johnson, A., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03434-5 · Cited by 22
Fagerlund, B., Pinborg, L. H., Mortensen, E. L., Friberg, L., Baaré, W. F. C., Gade, A., Svarer, C., & Glenthoj, B. Y. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571200003x · Cited by 21
“In healthy people, treatment with the D2 agonist bromocriptine has been found to improve spatial working memory, but impair reversal learning (Mehta et al. 2001).”
BackgroundIndependent effects of age and levodopa on reversal learning in healthy volunteers
Vo, A., Seergobin, K. N., & MacDonald, P. A. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.05.014 · Cited by 20
Ellis, K. A., Mehta, M. A., Wesnes, K. A., Armstrong, S., & Nathan, P. J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0019-2 · Cited by 22
Self-citationCognitive flexibility in humans and other laboratory animals
Highgate, Q., & Schenk, S. (2020) · Journal of the Royal Society of New Zealand · doi:10.1080/03036758.2020.1784240 · Cited by 22
Effects of dopaminergic modulation on electrophysiological brain response to affective stimuli
Franken, I. H. A., Nijs, I. M. T., & Pepplinkhuizen, L. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0941-6 · Cited by 23
Distributive justice and cognitive enhancement in lower, normal intelligence
Dunlop, M., & Savulescu, J. (2014) · Bioethics News · doi:10.1007/s40592-014-0014-7 · Cited by 27
“2008), while high-functioning individuals are less likely to be enhanced and may even suffer detrimental results (Mehta et al. 2001; Vijayraghavan et al. 2007).”
BackgroundBrožka, H., Radostová, D., Pištíková, A., Valeš, K., & Stuchlík, A. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00122 · Cited by 18
“Non-perseverative errors were observed in reversal learning in humans on spatial tasks after systemic administration of bromocriptine, another D2-like agonist (Mehta et al., 2001).”
BackgroundEffects of levodopa on stimulus-response learning versus response selection in healthy young adults
Vo, A., Seergobin, K. N., & MacDonald, P. A. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.10.019 · Cited by 21
Murphy, A., Dursun, S. M., McKie, S., Elliott, R., & Deakin, J. F. W. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4234-9 · Cited by 20
Attention deficit disorders: Are we barking up the wrong tree?
Cabral, P. (2006) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2006.02.004 · Cited by 21
Marighetto, A., Valério, S., Philippin, J.-N., Bertaina‐Anglade, V., Rochelle, C. D. L., Jaffard, R., & Morain, P. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107083836 · Cited by 17
Jin, X., Chen, Q., Song, Y., Zheng, J., Xiao, K., Shao, S. H., Fu, Z., Yi, M., Yang, Y., & Huang, Z. (2019) · The Journal of Physiology · doi:10.1113/jp277976 · Cited by 19
“Administration of the D2 agonist bromocriptine to human volunteers improves their short-term spatial memory (Mehta et al. 2001).”
BackgroundCognition-Enhancing Drugs and Their Appropriateness for Aviation and Ground Troops: A Meta-Analysis
Kelley, A. M., Webb, C. M., Athy, J. R., Ley, S. L., & Gaydos, S. (2010) · Defense Technical Information Center (DTIC) · doi:10.21236/ada533727 · Cited by 19
Mkrtchian, A., Qiu, Z., Abir, Y., Erdmann, T., Dercon, Q., Sedlinská, T., Browning, M. D., Costello, H., & Huys, Q. J. M. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2025.0839 · Cited by 19
Gelao, B., Fazio, L., Selvaggi, P., Giorgio, A. D., Taurisano, P., Quarto, T., Romano, R., Porcelli, A., Mancini, M., Masellis, R., et al. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3398-9 · Cited by 16
“…as it has previously been reported to modulate spatial short-term memory without producing appreciable adverse effects, unlike the higher dose of 2.5 mg (Luciana et al. 1998; Mehta et al. 2001; Gibbs and D'Esposito 2005a, b; Kirsch et al. 2006; Cools et al. 2007, 2009; van Holstein et al. 2011).”
InfluentialOnaolapo, O. J., & Onaolapo, A. Y. (2012) · Neuroscience Journal · doi:10.1155/2013/948241 · Cited by 16
Chung, Y., Park, T.-W., Yang, J.-C., Huang, G., Zhao, T., Oh, K.-Y., & Kim, M. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318272d10c · Cited by 15
Lack of Dopaminergic Modulation of Cognitive Flexibility
Smyth, S. F., & Beversdorf, D. Q. (2007) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0b013e31815e6244 · Cited by 15
Functional neuroimaging in Parkinson's disease
de la Fuente‐Fernández, R., Appel‐Cresswell, S., Doudet, D. J., & Sossi, V. (2011) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2011.554820 · Cited by 16
Robbins, T. W. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195373035.003.0014 · Cited by 18
Self-citationIndependent Component Analysis of the Effect of L-dopa on fMRI of Language Processing
Kim, N., Goel, P. K., Tivarus, M. E., Hillier, A. J., & Beversdorf, D. Q. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011933 · Cited by 15
Osugo, M., Zahid, U., Selvaggi, P., Chilimidos, A., Finelli, V., Chapman, G. E., Whitehurst, T., Onwordi, E. C., Murray, R. M., Wall, M. B., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03116-8 · Cited by 13
Self-citationExecutive Functions Of Persistent Violent Offenders: A Critical Review Of The Literature
Brito, S. A. D., & Hodgins, S. (2009) · Oxford University Press eBooks · doi:10.1093/oso/9780199543533.003.0010 · Cited by 21
Cognitive Diversity and Moral Enhancement
Gyngell, C., & Easteal, S. (2014) · Cambridge Quarterly of Healthcare Ethics · doi:10.1017/s0963180114000310 · Cited by 15
Ellis, K. A., Mehta, M. A., Murthy, P. J. N. V., McTavish, S. F. B., Nathan, P. J., & Grasby, P. M. (2007) · Human Brain Mapping · doi:10.1002/hbm.20339 · Cited by 15
Self-citationJaja, A. A., Grahn, J. A., Herrmann, B., & MacDonald, P. A. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.01.002 · Cited by 13
A Dual Effect of Dopamine on Hippocampal LTP and Cognitive Functions in Control and Kindled Mice
Ahmadi, M., Rouhi, N., Fathollahi, Y., Shojaei, A., Rezaei, M., Rostami, S., Saab, B. J., & Mirnajafi‐Zadeh, J. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0926-21.2023 · Cited by 14
Dopamine Alters the Effect of Brain Stimulation on Decision-Making
Leow, L., Marcos, A., Nielsen, E., Sewell, D. K., Ballard, T., Dux, P. E., & Filmer, H. L. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.1140-23.2023 · Cited by 11
Dopamine — Its Role in Behaviour and Cognition in Experimental Animals and Humans
Robbins, T. W., & Everitt, B. J. (2002) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-06765-9_7 · Cited by 14
Self-citationEffects of pharmacological inhibition of dopamine receptors on memory load capacity
Olivito, L., Risi, M. D., Russo, F., & Leonibus, E. D. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.10.041 · Cited by 11
Luciana, M. M. (2015) · Wiley eBooks · doi:10.1002/9780470939390.ch7 · Cited by 10
Methylphenidate does not enhance visual working memory but benefits motivation in macaque monkeys
Oemisch, M., Johnston, K., & Paré, M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.06.019 · Cited by 10
“, 2011), DA receptor agonists (Luciana et al., 1992, 1998; Kimberg et al., 1997; Luciana and Collins, 1997; Müller et al., 1998; Mehta et al., 2001; Bartholomeusz et al., 2003; Kimberg and D’Esposito, 2003; Gibbs and D’Esposito, 2005; see for review Cools and D’Esposito, 2011) or NE receptor agonist (Frith et al.”
BackgroundJones, R. W., Morris, K., & Nutt, D. J. (2007) · Elsevier eBooks · doi:10.1016/b978-012370624-9/50011-6 · Cited by 10
Geffe, S., Schindlbeck, K. A., Mehl, A., Jende, J. M. E., Klostermann, F., & Marzinzik, F. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1557-y · Cited by 11
Spiegelstein, O., Stevens, J., van Gerven, J., Nathan, P. J., Maynard, J., Mayleben, D. W., Hellriegel, E. T., & Yang, R. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116645301 · Cited by 8
“…tasks were chosen because of their sensitivity to neurochemical (e.g. dopamine, noradrenaline, and acetylcholine) modulation, and thus relevance to the mechanism of action of CEP-26401(Chamberlain et al., 2006; Mehta et al., 2001; Mehta et al., 2004; Sahakian et al., 1993; Turner et al., 2005).”
BackgroundNeurochemical modulation of orbitofrontal cortex function
Robbins, T. W., Clark, L., Clarke, H. F., & Roberts, A. (2006) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198565741.003.0016 · Cited by 8
Self-citationDopaminergic Modulation of Flexible Cognitive Control: The Role of the Striatum
Cools, R. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195314274.003.0017 · Cited by 7
Moustafa, A. A., Herzallah, M. M., & Gluck, M. A. (2013) · Journal of Mathematical Psychology · doi:10.1016/j.jmp.2013.08.003 · Cited by 7
Roberts, A. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195314274.003.0016 · Cited by 6
MacQueen, D. A., & Young, J. (2020) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2020.107159 · Cited by 6
Do Patients With Parkinson’s Disease Exhibit Reduced Cheating Behavior? A Neuropsychological Study
Abe, N., Kawasaki, I., Hosokawa, H., Baba, T., & Takeda, A. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00378 · Cited by 5
“Previous studies have demonstrated an “inverted U” shape relationship between levels of dopamine and dopamine-dependent cognitive abilities (38, 39).”
Hook, R. W., Isobe, M., Savulich, G., Grant, J. E., Ioannidis, K., Christmas, D. M. B., Sahakian, B. J., Robbins, T. W., & Chamberlain, S. R. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.03.006 · Cited by 4
Self-citationDopamine DRD2 polymorphism alters reversal learning and associated neural activity
Jocham, G., Klein, T., Neumann, J., von Cramon, D., Reuter, M., & Ullsperger, M. (2009) · NeuroImage · doi:10.1016/s1053-8119(09)71945-7 · Cited by 3
A neurological perspective on the enhancement debate: Lessons learned from Parkinson’s disease
Kehagia, A. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116665328 · Cited by 3
“…differences in baseline neurochemical state, which can be improved or ‘overdosed’; for example, the DA agonist bromocriptine improves working memory in low performing healthy individuals, but actually impairs it in those individuals whose performance is already high (e.g. Mehta et al., 2001).”
BackgroundShigemune, Y., Kawasaki, I., Midorikawa, A., Baba, T., Takeda, A., & Abe, N. (2021) · Neurological Sciences · doi:10.1007/s10072-020-04968-4 · Cited by 3
Context, goals, and behavioral regulation in schizophrenia: Psychological and neural mechanisms.
Barch, D. M., & Braver, T. S. (2009) · American Psychological Association eBooks · doi:10.1037/11884-002 · Cited by 3
Metadata
- Authors
- Mehta, M. A., Swainson, R., Ogilvie, A. D., Sahakian, B., & Robbins, T. W.
- Affiliations
- University of Cambridge (GB)
- Venue
- Psychopharmacology
- Published
- 2001-09-11
- Volume
- 159
- Issue
- 1
- Pages
- 10-20
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2060886872
- Cited by
- 235
- References
- 33
- Citations by year
- 2025: 5 · 2024: 3 · 2023: 6 · 2022: 5 · 2021: 1 · 2020: 5 · 2019: 7 · 2018: 10 · 2017: 4 · 2016: 15 · 2015: 6 · 2014: 13 · 2013: 14 · 2012: 11
- FWCI
- 2.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Wellcome Trust
- Medical Research Council
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- bromocriptine, spatial working memory, reversal learning, discrimination reversal, spatial planning, executive function, Parkinson's disease, dopaminergic therapy, subjective motivation
- MeSH terms
- Adult, Analysis of Variance, Bromocriptine, Double-Blind Method, Humans, Male, Memory, Short-Term, Neuropsychological Tests, Reaction Time, Reversal Learning, Receptors, Dopamine D2, Dopamine Agonists, Cross-Over Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.